Amicas to form healthcare IT leader with Emageon deal
This article was originally published in Clinica
Executive Summary
Medical information management firms Amicas and Emageon are set to form what they believe will be a leader in the field of healthcare IT, following a cash-for-stock merger. Amicas (Boston, Massachusetts) will acquire all outstanding Emageon shares for $1.82 each, giving the deal a total value of $39m. The tender offer will commence on March 5 and is expected to close in the second quarter of 2009. The newly-merged firm will offer radiology and cardiology PACS, radiology and cardiology information systems, revenue cycle management systems, referring physician tools, and business intelligence tools to hospitals and healthcare networks. According to Amicas, Birmingham, Alabama-based Emageon ended 2008 with reserves of $55m and no long-term debt.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals